Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan;12(1):48-60.
doi: 10.1038/nrneph.2015.158. Epub 2015 Oct 6.

Mechanisms and mediators of lung injury after acute kidney injury

Affiliations
Review

Mechanisms and mediators of lung injury after acute kidney injury

Sarah Faubel et al. Nat Rev Nephrol. 2016 Jan.

Abstract

Acute kidney injury (AKI) is a common complication in hospitalized patients, associated with >50% mortality in those in intensive care who require renal replacement therapy. Data suggest that AKI is a systemic disease that adversely affects the immune system and organ function, and in this way contributes to the high mortality observed in affected patients. Data from patients and animal models indicate that AKI adversely affects the lungs. Respiratory complications are common in patients with AKI and include pulmonary oedema, respiratory failure requiring mechanical ventilation, prolonged duration of mechanical ventilation, and prolonged weaning from mechanical ventilation. The development of respiratory failure in patients with AKI greatly increases the risk of death. Data from animal models support the notion that cardiogenic pulmonary oedema (from volume overload) and non-cardiogenic pulmonary oedema (from endothelial injury due to inflammation and apoptosis) can occur in AKI. In this Review we discuss the clinical, epidemiologic, and animal data that provide insights into the mechanisms by which AKI can lead to lung injury and respiratory complications. Elucidation of the mechanisms of lung injury and respiratory complications after AKI is essential to develop effective therapies and reduce the high mortality associated with AKI and respiratory failure.

PubMed Disclaimer

References

    1. Ann Surg. 1948 Sep;128(3):561-608 - PubMed
    1. Am J Physiol Lung Cell Mol Physiol. 2012 Sep;303(5):L449-59 - PubMed
    1. Intensive Care Med. 2007 Sep;33(9):1563-70 - PubMed
    1. Kidney Int. 2004 Apr;65(4):1357-65 - PubMed
    1. Shock. 1998 Sep;10(3):182-91 - PubMed

MeSH terms

LinkOut - more resources